DCF — KETCHIKAN MEDICAL CENTER
Enterprise Value: $-186.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-186.0M
Enterprise Value
$-58.1M
PV of Cash Flows
$-127.8M
PV of Terminal Value
$-205.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $95.2M | $-12.0M | -13.0% | $-16.0M | $-14.5M |
| Year 2 | $98.1M | $-11.4M | -12.0% | $-15.5M | $-12.8M |
| Year 3 | $101.0M | $-10.7M | -11.0% | $-15.0M | $-11.2M |
| Year 4 | $104.0M | $-10.5M | -10.0% | $-14.9M | $-10.2M |
| Year 5 | $107.2M | $-10.5M | -10.0% | $-15.1M | $-9.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-186.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$92.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.13076468473873545
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5